Haleon plc (HLN) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United Kingdom, listed on NYSE. Market cap 40.72B USD. 52-week range 8.65 to 11.28 USD. Trailing P/E 18.9. Data as of 2026-10-09.
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides ...